CRISPR Therapeutics (CRSP) Cash Flow Annual - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)

* (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2025-02-11 2024-02-21 2023-02-21 2022-02-15 2021-02-16 2020-02-12 2019-02-25 2018-03-08 2017-03-10 2015-12-31 2014-12-31
Net Income/Starting Line
-366 -154 -650 378 -349 66.9 -165 -68.4 -23.2 -25.8 -6.80
Cash From Operating Activities
-143 -260 -496 539 -238 56.7 -96.2 -70.1 -55.3 59.4 -4.79
Depreciation and Amortization
19.3 19.8 24.2 18.0 9.18 4.72 3.52 3.02 0.92 0.13 0.04
Deferred Income Tax
0.00 0.00 0.00 0.00 0.00 0.00 4.28 0.00 -53.7 -0.02 0.00
Stock Based Compensation
86.6 81.0 97.9 102 66.0 44.1 35.0 18.9 10.8 3.68 0.70
Other Non-Cash Items
-38.6 -14.0 12.5 14.1 1.86 -10.5 15.4 1.75 8.05 0.10 -0.26
Changes in Working Capital
156 -194 19.8 26.9 33.4 -48.4 10.6 -25.4 1.78 81.4 1.53
Accounts Receivable
175 -200 0.30 -0.16 -0.04 -0.01 2.54 0.53 -2.82 -0.34 0.00
Inventory
0.00 23.3 0.00 -37.5 -25.7 -5.03 332 -551 -1.09 0.00 0.00
Accounts Payable
0.00 -20.2 5.16 37.5 25.7 5.03 -323 547 3.86 0.00 0.00
Deferred Revenue
-18.7 3.33 14.4 27.0 33.5 -48.4 -1.00 -21.2 1.83 81.7 1.53
Other Working Capital
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash From Investing Activities
-280 375 -259 -1,035 -541 1.32 -2.77 -8.31 31.9 -1.15 0.00
Investments in Property Plant and Equipment
-1.90 -9.47 -37.2 -81.7 -18.4 -6.68 -2.77 -7.81 -3.02 -1.15 0.00
Payments for Acquisitions
0.00 0.00 221 954 523 8.01 0.00 0.00 -0.10 0.00 0.00
Purchases of Securities
-1,463 -1,066 -1,418 -1,509 -594 0.00 0.00 -0.50 -0.10 0.00 0.00
Sales and Maturities of Investments
1,208 1,453 1,196 556 71.2 0.00 0.00 0.00 0.00 0.00 0.00
Other Investing Activities
-23.2 -2.50 -221 -954 -523 8.01 0.00 -0.50 35.0 0.00 0.00
Cash From Financing Activities
332 62.7 38.6 251 1,016 431 316 2.61 183 96.7 5.12
Debt Repayment
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 35.0 38.2 0.00
Common Stock Issued
301 32.7 0.97 213 982 415 307 2.61 89.1 58.5 0.02
Common Stock Repurchased
0.00 0.00 0.00 0.00 0.00 0.00 -0.06 0.00 0.00 0.00 0.00
Dividends Paid
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Financing Activities
31.3 29.9 37.6 37.7 33.9 16.0 8.94 2.61 59.1 58.5 5.10
Effect of Forex Changes on Cash
-0.02 0.07 -0.08 -0.01 0.04 0.02 -0.02 0.04 -0.24 0.01 0.25
Net Change in Cash
-91.3 177 -716 -246 237 489 217 -75.8 160 155 0.58
Cash at Beginning of Period
401 224 940 1,185 949 460 243 316 156 0.94 0.36
Cash at End of Period
310 401 224 940 1,185 949 460 240 316 156 0.94
Free Cash Flow
-145 -272 -533 457 -257 50.0 -99.0 -77.9 -58.3 58.3 -4.79
Operating Cash Flow
-143 -260 -496 539 -238 56.7 -96.2 -70.1 -55.3 59.4 -4.79
Capital Expenditure
-1.90 -12.0 -37.2 -81.7 -18.4 -6.68 -2.77 -7.81 -3.02 -1.15 0.00
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us